TT-301

DB12899InvestigationalSmall molecule

TT301 has been used in trials studying the treatment of Traumatic Brain Injury.

Chemical structure of TT-301
Formula / weight
C23H21N7 · 395.47 g/mol (avg)
Code names
MW-01-6-189WH · MW-189 · TT301

Resolves to

Compound
UNIICY416F5NSKCAS886208-76-0PubChem54576073
Structure
InChIKeyZPJGUEPHFXPAQF-UHFFFAOYSA-NSMILESC1CN(CCN1C1=NC=CC=N1)C1=C(C=C(N=N1)C1=CC=CC=C1)C1=CC=NC=C1
Targets
P01584IL1B

What you can answer from here — as of November 03, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with TT-301, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In